Search results
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
United Press International via Yahoo News· 15 hours agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
Eli Lilly's Potential Alzheimer’s Drug Clears a Big Hurdle
Time via Yahoo News· 2 days ago"It's important to look at this milestone in the larger treatment landscape for Alzheimer's, which...
2024 Warren Alpert Foundation Prize Honors Four Pi | Newswise
Newswise· 3 days agoThe 2024 Warren Alpert Foundation Prize has been awarded to four scientists whose transformational discoveries led to the creation of chimeric antigen receptor (CAR) T cells, a treatment ...
Microrobots made of algae carry chemo directly to lung tumors, improving cancer treatment
San Francisco Chronicle· 1 day agoMy colleagues and I from the Wang lab and Zhang Research Group at the University of California, San Diego have spent the past five years developing biohybrid microrobots, tiny objects made of ...
Walking in the Light of Science-Min Li's Unending Quest in Cancer Treatment
Digital Journal· 3 days agoThe breakthrough by Dr. Li and her team not only provides new insights into the mechanisms of tumor drug resistance but also holds potential for developing new therapeutic strategies in precision ...
Microrobots made of algae carry chemo directly to lung tumors, improving cancer treatment
Stamford Advocate· 1 day agoConventional chemotherapy often falls short because it’s inefficient. It doesn’t directly target the lungs and accumulate in a high enough concentration to kill tumors. My colleagues and I from ...
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
UPI· 15 hours agoA study of more than 700 patients treated at Stanford University found that the risk of secondary ...
Study shows pre-targeted dual-isotope radionuclide therapy safe and effective in colorectal cancer
Medical Xpress· 2 days agoCombination of alpha- and beta-radionuclide therapy is feasible, tolerable, and effective for colorectal cancer, according to preclinical research presented at the 2024 Society ...
Unequal access to cancer breakthrough | Philly Health Insider
Philly.com· 2 days agoThis week, we have a deep dive into racial disparities in the Penn-developed cancer treatment CAR-T...
Y-mAbs presents preclinical data at SNMMI 2024 event By Investing.com
Investing.com· 6 days agoY-mAbs Therapeutics, Inc. (NASDAQ:YMAB), a commercial-stage biopharmaceutical firm, is set to...